“Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Pooled Analysis of Two Phase 3, Randomized, Double-Blind Studies” (2021) SKIN The Journal of Cutaneous Medicine, 5(1), p. s8. doi:10.25251/skin.5.supp.8.